UNSPSC 85725111: Revision of autologous tissue substitute in right sacroiliac joint, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in right sacroiliac joint, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SW737Z

UNSPSC 85725111 Revision of autologous tissue substitute in right sacroiliac joint, percutaneous approach is a Commodity code that shows minimal recent state and local procurement activity aligned with its clinical-procedure classification. The recent state and local solicitations tagged to this code do not reflect orthopedic joint-revision services; instead, they span occupational medical surveillance, disability medical evaluation, pharmacy benefit management, temporary health professional staffing, surgical carve-out benefit programs, and youth detention emergency medical services. The mismatch between the code's nominal scope and the actual work being solicited suggests either misclassification in state and local procurement systems or that this code does not represent active purchasing categories for state and local health authorities at this time.

The geographic spread of the few tagged records spans Washington State, Arizona, California, and Florida, with no concentration evident. No recent state and local opportunities specifically solicit orthopedic implant revision procedures, related implant materials, or associated surgical facility services under this code. The solicitations present—including the Washington State Department of Transportation's occupational medical surveillance RFP (due October 9, 2026), the City of Phoenix's disability medical evaluation RFP (due October 16, 2026), and the Collier County pharmacy benefit management RFP (original deadline April 9, 2026)—represent entirely different procurement categories unrelated to the code's stated clinical scope. State and local buyers do not appear to be using this code for active procurement in the orthopedic joint-revision market.